A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors

NCT05794477 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

BIOLOGICAL: Adebrelimab
BIOLOGICAL: SHR-1802
DRUG: Carboplatin/Cisplatin
DRUG: Paclitaxel/Nab-Paclitaxel/Pemetrexed

Sponsor

Shanghai Hengrui Pharmaceutical Co., Ltd.